Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.
about
Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease.Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.Self-discriminating fluorescent hybrid nanocrystals: efficient and accurate tracking of translocation via oral delivery.Colon-targeted delivery of cyclosporine A using dual-functional Eudragit® FS30D/PLGA nanoparticles ameliorates murine experimental colitis.
P2860
Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.
@en
type
label
Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.
@en
prefLabel
Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.
@en
P2860
P921
P1476
Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.
@en
P2093
Alf Lamprecht
John Youshia
P2860
P304
P356
10.1517/17425247.2016.1114604
P407
P577
2015-12-04T00:00:00Z